Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feb. 1, Vol. 25, No. 3

    • Columns

      • The Impact of Biotech Licensing
      • Biotechnology companies at all stages of growth need a robust technology platform and capital. StartUpCo, a hypothetical emerging biotech company, needs a technology platform and instant credibility to attract investors. Typically, StartUpCo looks t ... more »
    • Feature Articles

      • Advances in Microgenomics: Less is More
      • Once considered a limitation, small cell samples have now led to new technology advances that are providing researchers with faster and more accurate molecular information. These advances include separation methods to obtain pure cell populations, n ... more »
      • Antibody Therapeutics Dominate Meeting
      • Recombinant antibody therapeutics are moving to a next generation of products, according to a keynote address by Ronald Levy, M.D., given at IBC's recent meeting held in San Diego, "Antibody Engineering and Therapeutics." Dr. Levy is ... more »
      • Atlanta Bioscience Breaks into the Top Ten
      • The Atlanta metropolitan region ranks third nationally for the number of Fortune 500 companies headquartered there. Additionally, several medical organizations, such as the Centers for Disease Control and Prevention (CDC), the American Cancer Societ ... more »
      • Could London Become a Major Biotech Hub?
      • London's proximity to world-class universities providing high quality research and a thriving community of financial experts makes it an ideal place for biotech companies to locate, stated Jo Valentine, CEO of the business campaign group, London ... more »
      • High Throughput Screening of GPCRs
      • Kathy Liszewski
      • More than 50% of all current drugs and nearly 25% of the top 200 best-selling drugs target G-protein-coupled receptors (GPCRs).These heterotrimeric proteins contain seven membrane-spanning segments and consist of α, β, and γ subunits. To add to the ... more »

Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »